MRSO (TSE:5619) Current Deferred Revenue: 円0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:5619 MRSO Inc TSE:5619
40 GF Score
Price 円850.00
GF Value 円665.35
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is MRSO Current Deferred Revenue?

MRSO TSE:5619 +2.91% 40 Current Deferred Revenue is 円0 Mil as of Jun. 2026. GuruFocus rates TSE:5619 with a GF Score™ of 40/100 and a GF Value™ of 円665.35 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

MRSO's current deferred revenue for the quarter that ended in Jun. 2026 was 円0 Mil.

MRSO Current Deferred Revenue Related Terms

MRSO Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for MRSO's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRSO Current Deferred Revenue Chart

MRSO Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
0.00 0.00 0.00 0.00 0.00

MRSO Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:5619
40GF Score
MRSO Inc TSE:5619
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of 円0 Mil mean?
MRSO (TSE:5619) has a Current Deferred Revenue of 円0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on MRSO and its competitors.
Is MRSO's Current Deferred Revenue too high?
MRSO's current Current Deferred Revenue is 円0 Mil. Overall, MRSO has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MRSO's Current Deferred Revenue compare to VEEV and BTSG?
MRSO's Current Deferred Revenue of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on MRSO and its competitors. MRSO's current Current Deferred Revenue is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRSO stock overvalued right now?
Based on GuruFocus' analysis, MRSO (TSE:5619) is currently considered Modestly Overvalued. The stock's GF Value™ is 円665.35, compared to a current price of 円850.00 — trading 27.8% above its estimated fair value. The current Current Deferred Revenue is 円0 Mil. MRSO's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For MRSO (TSE:5619), the current Current Deferred Revenue is 円0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MRSO (TSE:5619) Overvalued in 2026?

Based on GuruFocus' analysis, MRSO stock appears to be overvalued. The current stock price of 円850.00 is trading 27.8% above its estimated GF Value™ of 円665.35. GuruFocus considers MRSO to be Modestly Overvalued.

Key valuation signals for TSE:5619:

  • Current Deferred Revenue: 円0 Mil
  • GF Value™: 円665.35 vs. price of 円850.00 (27.8% above fair value)
  • GF Score™: 40/100 with 3 warning signs

No single metric tells the full story. See the TSE:5619 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MRSO Business Description

Address Shiroyama Trust Tower 17th floor, 4-3-1 Toranomon, Minato-ku, Tokyo, JPN, 105-6017
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
40GF Score

Get the complete analysis for TSE:5619

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円850.00
Price
円665.35
GF Value